Unibest
← Back to patent-cliff list

CAS 1297537-33-7

(S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide

Codes: ODM-201-009

Application context (from source-drug indications)

Hormone-sensitive prostate cancerDarolutamideCastration-sensitive prostate cancerDarolutamideProstate cancerDarolutamideCastration-resistant prostate cancerDarolutamide

Source drugs (routes using this intermediate)

DrugTierExpiry
DarolutamideTier B — Position early2031

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works4-Bromo-2-chlorobenzonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.